Metformin/teneligliptin - Handok Pharmaceuticals
Alternative Names: HL1511; Metformin/MP-513; MP-513/metformin; Tenelia M SR; Teneligliptin/metforminLatest Information Update: 11 Dec 2025
At a glance
- Originator Handok Inc
- Class Antihyperglycaemics; Biguanides; Ketones; Piperazines; Pyrazoles; Small molecules; Thiazolidines
- Mechanism of Action AMP activated protein kinase stimulants; Dipeptidyl peptidase 4 inhibitors; Gluconeogenesis inhibitors
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Type 2 diabetes mellitus